Navigation Links
The Federal Trade Commission Files Lawsuit Seeking an Injunction Against Marketer of Weight-loss Products Over Alleged False Advertising, Parker Waichman LLP Reports

New York, New York (PRWEB) November 01, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of consumers, is informing the public that The Federal Trade Commission (FTC) has filed a lawsuit to obtain an injunction against the marketer of HCG Platinum weight-loss products, alleging the company uses false consumer advertising to convey the impression that its products are capable of bringing about the swift loss of substantial amounts of weight. The lawsuit was filed on Oct. 30, 2013, in U.S. District Court, District of Arizona (Case No. 2:13-cv-02215). Kevin Wright, HCG Platinum LLC and Right Way Nutrition LLC have been named defendants.

The weight-loss products marketed by the defendants contain HCG (human chorionic gonadotropin), a hormone in human placenta that “for decades has been falsely promoted by various marketers for weight loss,” according to the FTC’s Complaint. Products containing this hormone have already been in the spotlight as part of a combined effort between the FTC and the U.S. Food and Drug Administration (FDA), according to the Complaint, which further noted that in November 2011 the two agencies jointly sent warning letters to seven marketers of products that contained HCG – a group that included current defendant Kevin Wright. The warning letter revealed that the products offered by those marketers were actually mislabeled drugs in violation of sections of the Federal Food, Drug, and Cosmetic Act, and also illegal, based on the FTC Act, which renders illegal any weight loss claims not supported by reliable scientific evidence, according to the Complaint.

“The weight-loss business is rife with companies using unsupported marketing claims to promote what are usually lose-weight-quick products or schemes that don’t work,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “This is a consumer product category where the old adage ‘if it seems too good to be true, it probably is’ certainly fits.” Parker Waichman is currently evaluating cases for a pending class action lawsuit.

Marketing claims—featured on both packaging and in advertising—are a major concern, the Complaint said, noting that the marketers of the HCG Platinum line make various claims, including:

  •     Consumers will lose a pound or two per day for several weeks, for a total of up to 127 pounds;
  •     The products are safe and have been clinically proven to burn fat and reduce weight; and
  •     The products also can lower cholesterol.

If you or someone you know purchased an HCG Platinum brand product for personal use, you may have valuable legal rights. To find out more about joining an HCG Platinum class action lawsuit, please visit our website or contact one of our experienced class action lawyers today at 1(800)-LAW-INFO (1-800-529-4636).

Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mirena Lawsuits Mount, as Bernstein Liebhard LLP Notes More than 400 Mirena IUD Lawsuit Filings in State, Federal Litigations
2. New report: Companies created from federally funded university research fuel american innovation, economic growth
3. Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
4. Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
5. Mirena IUD Lawsuit Help Update: Resource4thePeople Comments on New Developments in State and Federal Court Litigation
6. U.S. Federal Panel Vacates Order to Transfer Mirena Lawsuit to New York Litigation, Bernstein Liebhard LLP Reports
7. New Transvaginal Mesh Lawsuits Assistance: Resource4thePeople Reports Key Trials Scheduled by Federal Judge
8. Status Conference Scheduled for December in Federal Ethicon Transvaginal Mesh Lawsuit Litigation, More than 10,270 Gynecare Cases Now Filed in Proceeding
9. Over 2,500 Cases Now Filed in Federal Actos Lawsuit Litigation; Case Management Conference Scheduled to Take Place on Thursday
10. PCMA: Eight Ways to Reduce Federal Health Spending and Improve Prescription Drug Benefits in Medicare and Medicaid
11. Wright Hip Lawsuit News: Federal Judge Allows Certain Claims to Proceed in Wright Profemur Hip Replacement Lawsuit, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: